C9orf153 Activators
C9orf153 Activators are an group of chemicals that engage with various signaling pathways to enhance the functional activity of C9orf153, a protein encoded by the C9orf153 gene. Some activators work by directly stimulating adenylyl cyclase, subsequently increasing cyclic AMP levels which, through a series of phosphorylation events, can elevate the activity of C9orf153. The rise in cAMP levels can activate protein kinase A, which then phosphorylates transcription factors, potentially leading to increased C9orf153 expression. Other activators inhibit phosphodiesterases, preventing the breakdown of cAMP and cGMP, which can indirectly result in the activation of C9orf153 by maintaining elevated levels of these cyclic nucleotides. This non-specific inhibition facilitates the sustained activity of both protein kinase A and protein kinase G, which are known to phosphorylate a range of proteins that can indirectly enhance the activity of C9orf153.
Some activators in the collection modulate intracellular calcium levels, either by acting as ionophores or by influencing calcium channels, thereby indirectly escalating the activity of calcium/calmodulin-dependent protein kinases. These kinases can phosphorylate various proteins in signaling pathways that are hypothesized to upregulate C9orf153 activity. In addition, there are activators that target the PI3K/AKT pathway, which is crucial for multiple cellular processes; inhibition of this pathway can lead to the activation of downstream proteins that may positively regulate C9orf153. Other compounds in the repertoire inhibit tyrosine kinases or tyrosine phosphatases, which canpotentially affect the phosphorylation status of proteins within pathways that are believed to activate C9orf153. This modulation of phosphorylation cascades is key to the regulation of C9orf153 activity, as phosphorylation is a critical post-translational modification that can alter protein function, localization, and interaction with other cellular components, thereby influencing the activity of C9orf153.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, potentially raising their levels and thereby activating PKA or PKG indirectly leading to increased activity of C9orf153 through phosphorylation of transcription factors. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which may phosphorylate transcription factors or other proteins that upregulate the activity of C9orf153 by changing its conformation or stability. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Increases intracellular calcium levels, which can activate calcium/calmodulin-dependent protein kinases (CaMKs) that could enhance the activity of C9orf153 through phosphorylation of proteins in its pathway. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore that raises intracellular calcium levels, potentially activating CaMKs and possibly leading to the upregulation of C9orf153 activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Specific inhibitor of phosphodiesterase type 4, elevating intracellular cAMP levels, and potentially enhancing the activity of C9orf153 through PKA-dependent signaling pathways. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Inhibitor of phosphodiesterase types 5, 6, and 9, thereby increasing cGMP levels which might activate PKG signaling pathways, leading to increased C9orf153 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits the phosphoinositide 3-kinases (PI3K), which may lead to activation of downstream proteins that positively influence C9orf153 activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor that may modulate phosphorylation pathways, potentially leading to altered activity of proteins that regulate C9orf153 activity. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Inhibitor of tyrosine phosphatases, potentially leading to enhanced tyrosine phosphorylation of proteins within pathways that activate C9orf153. | ||||||